XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Countries with confirmed cases of new mpox variant



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>FACTBOX-Countries with confirmed cases of new mpox variant</title></head><body>

Updates number of cases for DRC, Burundi and Uganda

Aug 22 (Reuters) -The World Health Organization declared mpox a global public health emergency for the second time in two years, following an outbreak of the viral infection in the Democratic Republic of Congo that has spread to neighbouring countries.

A new form of the virus, clade Ib, triggered global concern as it seems to be spreading quickly and little is known about the strain. The disease transmits through close contact.

The new strain has spread to at least two countries outside Africa.

The following are the countries that have reported cases of clade Ib mpox:


DEMOCRATIC REPUBLIC OF CONGO

Two strains of mpox are spreading in the Democratic Republic of Congo - the endemic clade I and the new clade Ib, which spreads more easily through close contact, including sexual.

As of August 11, DRC has seen a total of 3,235 cases and 19 deaths in 2024. The country has confirmed 38 cases of mpox in the past two weeks, according to WHO data.

SWEDEN

Global health officials on August 15 confirmed an infection with a new strain of the mpox virus in Sweden, the first sign of its spread outside the African continent.

Swedish health officials said at a press conference that the person was infected while in Africa with the clade Ib type of mpox involved in the recent outbreak. The person is receiving treatment.


THAILAND

An mpox case reported in Thailand was confirmed to be of the clade Ib strain of the virus, the first in the country, a disease control official said on Aug. 22.

The case was first reported on Aug. 21, and Thailand had said it was a 66-year-old European man who had arrived from an African country where the disease was spreading.

BURUNDI

As of August 18, Burundi has 153 cases of clade Ib mpox with zero deaths. The country reported 113 cases of clade Ib mpox in the past two weeks, according to WHO data.


KENYA

On July 29, Kenya's health ministry confirmed one case of clade Ib mpox, the first-ever case of mpox identified in the country. No deaths had been reported as of August 8, according to WHO data.


RWANDA

As of August 7, four confirmed clade Ib mpox cases and zero deaths had cumulatively been reported by the country, according to WHO data.


UGANDA

As of August 18, Uganda has identifiedthree cases of clade Ib mpox, with no deaths, according to WHO data. The cases are among thefirst confirmed mpox cases identified in the country.



Reporting by Sneha S K, Sriparna Roy and Puyaan Singh in Bengaluru; Editing by Vijay Kishore

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.